Pretreatment thrombocytosis: A prognostic marker for oral squamous cell carcinoma?: A prognostic marker for oral squamous cell carcinoma?

Oral and Maxillofacial Surgery

Volumn 16, Issue 2, 2012, Pages 197-200

  Kargus, Steffen ^a   Weber, Franz E ^a   Luebbers, Heinz T ^a   Zemann, Wolfgang ^a   Graetz, Klaus W ^a   Kruse, Astrid L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Head and neck cancer; Oral squamous cell carcinoma; Prognosis; Thrombocytosis

Indexed keywords

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; REFERENCE VALUE; SECOND CANCER; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PLATELET COUNT; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REFERENCE VALUES; THROMBOCYTOSIS; YOUNG ADULT;

EID: 84861684817     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-011-0305-6     Document Type: Article

References (23)

1. Woolgar JA (2006) Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42(3): 229-239.
2. Kruse AL, Luebbers HT, Gratz KW (2010) C-reactive protein levels: a prognostic marker for patients with head and neck cancer? Head Neck Oncol 2: 21.
3. Becker A et al (2000) Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46(2): 459-466.
4. Riess L (1872) Pathology of the blood [authors translation]. Arch Anat Physiol Wissensch Med 39: 237-249.
5. Erdemir F et al (2007) Clinical significance of platelet count in patients with renal cell carcinoma. Urol Int 79(2): 111-116.
6. Nyasavajjala SM et al (2010) Is there a role for pre-operative thrombocytosis in the management of colorectal cancer? Int J Surg 8(6): 436-438.
7. Gorelick C et al (2009) Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer 19(8): 1384-1389.
8. Taucher S et al (2003) Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 89(6): 1098-1106.
9. Ikeda M et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9(3): 287-291.
10. Tomita M et al (2008) Prognostic impact of thrombocytosis in resectable non-small cell lung cancer. Interact Cardiovasc Thorac Surg 7(4): 613-615.
11. Shimada H et al (2004) Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 198(5): 737-741.
12. Lu CC et al (2007) Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma. Oral Oncol 43(3): 283-288.
13. Gucer F et al (1998) Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 70(2): 210-214.
14. Menczer J et al (1998) Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 19(1): 82-84.
15. Mehta P (1984) Potential role of platelets in the pathogenesis of tumor metastasis. Blood 63(1): 55-63.
16. Karpatkin S, Pearlstein E (1981) Role of platelets in tumor cell metastases. Ann Intern Med 95(5): 636-641.
17. Tomita M et al (2010) Prognostic significance of the combined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer. Gen Thorac Cardiovasc Surg 58(11): 573-576.
18. Suppiah R et al (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107(8): 1793-1800.
19. Tranum BL, Haut A (1974) Thrombocytosis: platelet kinetics in neoplasia. J Lab Clin Med 84(5): 615-619.
20. Sierko E, Wojtukiewicz MZ (2004) Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30(1): 95-108.
21. Kaser A et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98(9): 2720-2725.
22. Vaupel P, Mayer A, Hockel M (2006) Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol 182(2): 63-71.
23. Verheul HM et al (1997) Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3(12 Pt 1): 2187-2190.